Previous product
Back to products
Zejula (niraparib)
CHF5,986.42
Next product
Tagrisso (osimertinib)
CHF6,838.00
Rydapt (midostaurin)
CHF17,528.19
Rydapt (midostaurin) is a medication used for the treatment of patients with newly diagnosed acute myeloid leukemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
Reviews
There are no reviews yet.